Search Result

Results for "

OX40/TNFRSF4 agonist

" in MedChemExpress (MCE) Product Catalog:

By Targets:	5-HT Receptor (599) Acetyl-CoA Carboxylase (1) ADC Linker (4) ADC Payload (23) Adenosine Receptor (114) Adenylate Cyclase (9) Adhesion G Protein-coupled Receptors (AGPCRs) (4) Adiponectin Receptor (5) Adrenergic Receptor (547) Akt (69) Aldehyde Dehydrogenase (ALDH) (3) Aldose Reductase (2) Amino Acid Derivatives (7) Aminotransferases (Transaminases) (1) AMPK (9) Amylin Receptor (8) Amyloid-β (13) Androgen Receptor (33) Angiotensin Receptor (29) Angiotensin-converting Enzyme (ACE) (2) ANGPTL (1) Annexin A (1) Antibiotic (39) Antibody-Drug Conjugates (ADCs) (2) AP-1 (2) Apelin Receptor (APJ) (30) Apolipoprotein (2) Apoptosis (284) Aquaporin (1) Arf Family GTPase (1) Arrestin (25) Aryl Hydrocarbon Receptor (47) Atg8/LC3 (1) ATP Citrate Lyase (1) Autophagy (188) Bacterial (88) Bcl-2 Family (20) Beta-secretase (1) Biochemical Assay Reagents (19) Bombesin Receptor (10) Bradykinin Receptor (13) c-Met/HGFR (2) C-type Lectin-like Receptors (CTLRs) (1) Cadherin (1) Calcium Channel (73) Calmodulin (2) CaMK (4) Cannabinoid Receptor (131) Carboxylesterase (CES) (2) Caspase (19) CaSR (27) Cathepsin (2) CCR (7) CD1 (3) CD19 (1) CD20 (1) CD28 (2) CD47 (3) CDK (6) CFTR (3) CGRP Receptor (9) Chemerin Receptor (2) CHIKV (1) Cholecystokinin Receptor (15) Cholinesterase (ChE) (15) ClpP (3) CMV (1) Collagen (4) Complement System (24) COMT (7) Constitutive Androstane Receptor (6) COX (14) CRFR (23) CXCR (33) Cyclic GMP-AMP Synthase (3) Cyclin G-associated Kinase (GAK) (2) Cytochrome P450 (55) Dengue Virus (7) Deubiquitinase (1) Dipeptidyl Peptidase (2) DNA/RNA Synthesis (5) Dopamine Receptor (301) Dopamine Transporter (9) Drug Derivative (11) Drug Intermediate (11) Drug Isomer (10) Drug Metabolite (71) Drug-Linker Conjugates for ADC (18) E1/E2/E3 Enzyme (4) EAAT (3) EBI2/GPR183 (4) EGFR (7) Endogenous Metabolite (414) Endothelin Receptor (15) Enterovirus (6) Ephrin Receptor (5) Epigenetic Reader Domain (5) Epoxide Hydrolase (1) ERK (63) Estrogen Receptor/ERR (131) Eukaryotic Initiation Factor (eIF) (3) FAAH (3) FAP (1) Fatty Acid Synthase (FASN) (1) Ferroptosis (44) FGFR (1) Flavivirus (7) Fluorescent Dye (6) Formyl Peptide Receptor (FPR) (27) FOXO (1) Free Fatty Acid Receptor (75) Fungal (13) FXR (69) G protein-coupled Bile Acid Receptor 1 (32) G Protein-coupled Receptor Kinase (GRK) (3) G2A (GPR132) (2) GABA Receptor (162) GCGR (83) GDNF Receptor (4) GHSR (34) GLP Receptor (99) Glucocorticoid Receptor (85) Glucokinase (1) GLUT (1) Glutathione Peroxidase (1) Glutathione Reductase (GR) (1) Glycosidase (4) GlyT (7) GnRH Receptor (22) GPR109A (15) GPR119 (30) GPR139 (4) GPR171 (5) GPR35 (22) GPR39 (5) GPR52 (4) GPR55 (9) GPR6 (1) GPR65 (1) GPR68 (1) GPR84 (15) GPR88 (9) GSK-3 (3) Guanylate Cyclase (12) HBV (12) HCN Channel (6) HCV (12) HCV Protease (2) HDAC (3) Hedgehog (4) HIF/HIF Prolyl-Hydroxylase (11) Histamine Receptor (114) Histone Demethylase (1) Histone Methyltransferase (17) HIV (26) HMG-CoA Reductase (HMGCR) (2) HSP (5) HSV (25) Hydroxycarboxylic Acid Receptor (HCAR) (10) IAP (1) IFNAR (15) IGF-1R (2) iGluR (126) IKK (2) IKZF Family (2) Imidazoline Receptor (23) Influenza Virus (13) Insecticide (17) Insulin Receptor (31) Integrin (14) Interleukin Related (59) IPK Superfamily (2) IRAK (6) Isotope-Labeled Compounds (401) Itk (2) JAK (5) JNK (11) Keap1-Nrf2 (8) Kisspeptin Receptor (5) LDLR (10) Leukotriene Receptor (12) Ligands for Target Protein for PROTAC (3) Liposome (13) Lipoxygenase (1) LPL Receptor (79) LXR (43) mAChR (150) MAP3K (2) MAPKAPK2 (MK2) (1) MARCKS (2) Mas-related G-protein-coupled Receptor (MRGPR) (17) MCHR1 (GPR24) (5) MDM-2/p53 (7) MEK (3) Melanocortin Receptor (60) Melatonin Receptor (36) mGluR (84) MHC (5) MicroRNA (3) Microtubule/Tubulin (3) Mineralocorticoid Receptor (4) Mitochondrial Metabolism (4) Mitophagy (15) Mitosis (2) MMP (14) Monoamine Oxidase (6) Monoamine Transporter (2) Motilin Receptor (7) mRNA (2) mTOR (10) Na+/K+ ATPase (1) nAChR (172) NADPH Oxidase (2) Natriuretic Peptide Receptor (NPR) (3) Necroptosis (5) Neurokinin Receptor (33) Neuromedin U Receptor (NMUR) (5) Neuropeptide B/W Receptor (4) Neuropeptide FF Receptor (7) Neuropeptide S Receptor (3) Neuropeptide Y Receptor (64) Neurotensin Receptor (6) NF-κB (72) NO Synthase (30) NOD-like Receptor (NLR) (15) Notch (2) Nuclear Factor of activated T Cells (NFAT) (3) Nuclear Hormone Receptor 4A/NR4A (28) Nucleoside Antimetabolite/Analog (9) Olfactory Receptor (4) Opioid Receptor (268) Orexin Receptor (OX Receptor) (48) Organoid (2) Orphan GPCR (1) Orphan Nuclear Receptor (3) Orphan Receptor (16) Oxytocin Receptor (17) P-glycoprotein (3) P-selectin (1) P2X Receptor (10) P2Y Receptor (53) p38 MAPK (42) p62 (1) PACAP Receptor (2) PAK (9) Parasite (36) PARP (1) PD-1/PD-L1 (5) PDHK (1) PDK-1 (1) PERK (3) PGC-1α (1) PGE synthase (2) Phosphatase (11) Phosphodiesterase (PDE) (11) Phospholipase (4) Phytohormone (1) PI3K (24) Piezo Channel (5) PINK1/Parkin (4) PKA (12) PKC (6) PKD (3) PKG (9) Platelet-activating Factor Receptor (PAFR) (4) Potassium Channel (59) PPAR (312) Pregnane X Receptor (PXR) (8) Progesterone Receptor (22) Prostaglandin Receptor (148) PROTACs (3) Protease Activated Receptor (PAR) (44) Proton Pump (5) PTEN (2) PTHR (6) Pyroptosis (1) RAR/RXR (87) Ras (9) Reactive Oxygen Species (ROS) (62) Reference Standards (419) Renin (3) REV-ERB (9) Reverse Transcriptase (3) RGS Protein (1) ROR (67) ROS Kinase (2) RXFP Receptor (19) SARS-CoV (35) Ser/Thr Kinase (1) Serotonin Transporter (27) Serpin (1) SHP1 (1) Sigma Receptor (61) Sirtuin (9) Small Interfering RNA (siRNA) (3) Smo (16) SOD (4) Sodium Channel (19) Somatostatin Receptor (45) SOS1 (1) Src (1) STAT (13) Stearoyl-CoA Desaturase (SCD) (1) STING (111) Succinate Dehydrogenase (1) Succinate Receptor 1 (1) Survivin (1) Syk (1) Target Protein Ligand-Linker Conjugates (1) Taste Receptor (3) TGF-beta/Smad (11) TGF-β Receptor (5) Thrombin (4) Thrombopoietin Receptor (25) Thyroid Hormone Receptor (56) TNF Receptor (67) Toll-like Receptor (TLR) (240) Trace Amine-associated Receptor (TAAR) (18) Transmembrane Glycoprotein (8) TREM receptor (5) Trk Receptor (12) TRP Channel (115) TSH Receptor (4) Tyrosinase (3) UGT (1) Urotensin Receptor (10) Vasopressin Receptor (30) VD/VDR (19) VEGFR (8) Virus Protease (5) VISTA (1) Wnt (22) Xanthine Oxidase (1) YAP (1) Zinc Finger Protein (1) α-synuclein (7) β-catenin (20)
By Research Areas:	Cancer (1232) Cardiovascular Disease (728) Endocrinology (758) Infection (282) Inflammation/Immunology (1404) Metabolic Disease (1070) Neurological Disease (2399)
Click Chemistry:	DBCO (1) Azide (7) Alkynes (17)
Oligonucleotides:	Adenosine (1) Fillers (1) Nucleotide Analogs (2) Rat Pre-designed siRNA Sets (1) mRNA (2) Phospholipids (4) Antisense Oligonucleotides (4) Cholesterol (1) Adenine Nucleotide (1) siRNAs (3) Pegylated Lipids (3) MicroRNAs (2) Nucleoside Analogs (2) CpG ODNs (37) Emulsifiers (1) Mouse Pre-designed siRNA Sets (1) Adjuvant (5) Human Pre-designed siRNA Sets (1)

6133

Inhibitors & Agonists

Screening Libraries

Fluorescent Dye

Biochemical Assay Reagents

759

Peptides

Inhibitory Antibodies

460

Natural
Products

Recombinant Proteins

515

Isotope-Labeled Compounds

Antibodies

Click Chemistry

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P991052

GSK-3174998	TNF Receptor	Cancer
GSK-3174998 is a humanized IgG1 *OX40/TNFRSF4* agonistic monoclonal antibody. GSK-3174998 has the potential for the study of advanced solid tumors. The isotype control for GSK-3174998 can refer to Human IgG1 kappa, Isotype Control (HY-P99001) .

HY-P991337

YH-002	Orexin Receptor (OX Receptor)	Cancer
YH-002 is a human IgG1 monoclonal antibody (mAb) targeting TNFRSF4/OX40/CD134. YH-002 binds to OX40 by mimicking the function of OX40L .

HY-P991339

ZL-1101	Orexin Receptor (OX Receptor)	Cancer
ZL-1101 is a human monoclonal antibody (mAb) targeting TNFRSF4/OX40/CD134.

HY-174514

*Human TNFRSF4* mRNA**	mRNA	Cancer
Human TNFRSF4 mRNA encodes the human TNF receptor superfamily member 4 (TNFRSF4) protein, a member of the TNF receptor superfamily. TNFRSF4 has been shown to activate NF-kappaB through its interaction with adaptor proteins TRAF2 and TRAF5.

HY-P991338

MEDI-6469	Orexin Receptor (OX Receptor)	Cancer
MEDI-6469 is a human monoclonal antibody (mAb) targeting TNFRSF4/OX40/CD134. MEDI-6469 targets the OX40 receptor on activated T cells to enhance the immune response against cancer cells. .

HY-P991334

INCAGN1949	Orexin Receptor (OX Receptor)	Cancer
INCAGN1949 is a human IgG1 monoclonal antibody (mAb) targeting TNFRSF4/OX40/CD134. INCAGN1949 selectively deplete intratumoral regulatory T cells .

HY-RS14814

TNFRSF4 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
TNFRSF4 Human Pre-designed siRNA Set A contains three designed siRNAs for TNFRSF4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TNFRSF4 Human Pre-designed siRNA Set A TNFRSF4 Human Pre-designed siRNA Set A

HY-RS16980

Tnfrsf4 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Tnfrsf4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Tnfrsf4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tnfrsf4 Mouse Pre-designed siRNA Set A Tnfrsf4 Mouse Pre-designed siRNA Set A

HY-RS23423

Tnfrsf4 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Tnfrsf4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Tnfrsf4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tnfrsf4 Rat Pre-designed siRNA Set A Tnfrsf4 Rat Pre-designed siRNA Set A

HY-P991335

BAT6026	Orexin Receptor (OX Receptor)	Cancer
BAT6026 is a human monoclonal antibody (mAb) targeting TNFRSF4/OX40/CD134. BAT6026 significantly reduces Treg cells and increased CD8+ T cells in tumor .

HY-P990678

Vonlerizumab	TNF Receptor	Inflammation/Immunology
Vonlerizumab is a CHO-expressed humanized antibody targeting *TNFRSF4/OX40/CD134*. Vonlerizumab carries a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145.22 kDa. The isotype control for Vonlerizumab can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990559

BMS-986178	TNF Receptor	Inflammation/Immunology
BMS-986178 is a humanized antibody expressed in CHO, targeting *TNFRSF4/OX40/CD134*. BMS-986178 has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for BMS-986178 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990115

*Anti-Mouse OX40/CD134 Antibody (OX-86)*	Orexin Receptor (OX Receptor)	Inflammation/Immunology Cancer
Anti-Mouse OX40/CD134 Antibody (OX-86) is an anti-mouse *OX40/CD134* IgG1 monoclonal antibody. Anti-Mouse OX40/CD134 Antibody (OX-86) can enhance the anti-tumor function of CD8 ⁺ T cells. Anti-Mouse OX40/CD134 Antibody (OX-86) can reverse immune suppression, enhance antigen presentation and T cell activation. Anti-Mouse OX40/CD134 Antibody (OX-86) can be used for research on cancer such as papilloma and leukemia ^[4].

HY-P990176

*Anti-Mouse OX40/CD134 (LALA-PG) Antibody (OX86)*	Orexin Receptor (OX Receptor)	Inflammation/Immunology Cancer
Anti-Mouse OX40/CD134 (LALA-PG) Antibody (OX86) is an anti-mouse OX40/CD134 (LALA-PG) IgG2a monoclonal antibody. Anti-Mouse OX40/CD134 (LALA-PG) Antibody (OX86) is a chimeric antibody of the original OX86 antibody (HY-P990115). Anti-Mouse OX40/CD134 (LALA-PG) Antibody (OX86) can significantly enhance the generation of antigen-specific effector T cells. Anti-Mouse OX40/CD134 (LALA-PG) Antibody (OX86) can be used for research on cancer .

HY-P99393

Tavolixizumab MEDI 0562; Tavolimab	TNF Receptor	Cancer
Tavolixizumab (MEDI 0562; Tavolimab) is a human monoclonal antibody to TNFRSF4 (TNF receptor superfamily member 4) for use in cancer immunology research .

HY-P99408

Oxelumab R 4930; huMAb OX 40L; Ro 49-89991	Interleukin Related	Inflammation/Immunology
Oxelumab (R 4930) is a human monoclonal antibody against the OX40 ligand (OX40L). Oxelumab can be used for the research of asthma .

HY-P99836

Cudarolimab IBI101	Orexin Receptor (OX Receptor)	Inflammation/Immunology Cancer
Cudarolimab (IBI101) is a completely human anti-OX40 (CD134, a co stimulating molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has antitumor activity and can be used in cancer related research .

HY-P991125

Cenzestotug	TNF Receptor	Inflammation/Immunology Cancer
Cenzestotug is a monoclonal antibody targeting human tumor necrosis factor receptor superfamily member 4 (TNFRSF4). Cenzestotug activates relevant immune cells by binding to *TNFRSF4*, exerting immunostimulatory and antitumor activities. Cenzestotug is promising for research of cancer immunotherapy .

HY-P99945

Revdofilimab ABBV-368	Orexin Receptor (OX Receptor)	Inflammation/Immunology Cancer
Revdofilimab (ABBV-368) is a human IgG1 agonist monoclonal antibody against *OX40. Among them, OX40* is a member of the TNF receptor superfamily expressed on activated and memory T cell subsets and T regulatory cells .

HY-P990175

*Anti-Mouse OX40L/CD134L Antibody (RM134L)*	Orexin Receptor (OX Receptor)	Inflammation/Immunology Cancer
Anti-Mouse OX40L/CD134L Antibody (RM134L) is an anti-mouse *OX40L/CD134L* IgG2b monoclonal antibody. Anti-Mouse OX40L/CD134L Antibody (RM134L) reduces immune response by inhibiting the OX40/OX40L signaling pathway. Anti-Mouse OX40L/CD134L Antibody (RM134L) can inhibit plasma cell differentiation and antibody secretion. Anti-Mouse OX40L/CD134L Antibody (RM134L) can prolong the survival time of cell transplantation by inhibiting CD4 ⁺ T cells. Anti-Mouse OX40L/CD134L Antibody (RM134L) can be used for researches on inflammation and cancer such as graft versus host disease (GVHD), allergic reaction, lupus nephritis and hepatocellular carcinoma (HCC) ^[4].

HY-P991336

Ordastobart INBRX-106; ES-102	Orexin Receptor (OX Receptor)	Inflammation/Immunology Cancer
Ordastobart (INBRX-106; ES-102) is a hexavalent *OX40* agonist antibody. Ordastobart enhances *OX40* receptor clustering, signaling, and downstream activation, thereby increasing the proliferation and activation of CD4 ⁺ and CD8 ⁺ T cells in vitro and in vivo. Ordastobart exhibits anti-tumor effects and improves survival in mouse models of cancer. Ordastobart is indicated for research in cancers such as fibrosarcoma and colorectal cancer .

HY-P99955

Rocatinlimab AMG 451; KHK4083	Orexin Receptor (OX Receptor)	Infection Inflammation/Immunology
Rocatinlimab (AMG 451) (KHK4083) is a fully human, non-fucosylated, *immunoglobulin G1 (IgG1) anti-OX40* monoclonal antibody**. Rocatinlimab can be used for the research of atopic dermatitis (AD) .

HY-P99249

Vonlerolizumab Pogalizumab; MOXR 0916	TNF Receptor	Cancer
Vonlerolizumab (MOXR 0916) is a humanized IgG agonistic monoclonal *OX40-specific* antibody. Vonlerolizumab can be used for the research of cancer .

HY-P991613

BGB-A445	Orexin Receptor (OX Receptor) NF-κB	Cancer
BGB-A445 is a humanized non-ligand-blocking agonistic OX40 monoclonal antibody with high affinity to OX40. BGB-A445 activates downstream NF-κB pathway to induce immune cell activation, proliferation, and survival. BGB-A445 dose-dependently and significantly depletes regulatory T cells via antibody-dependent cellular cytotoxicity (ADCC). BGB-A445 demonstrates robust and dose-dependent antitumor efficacy in the MC38 mice models. BGB-A445 can be used for the researches of cancer, such as colon adenocarcinoma .

HY-P99911

Efizonerimod alfa	Orexin Receptor (OX Receptor)	Inflammation/Immunology Cancer
Efizonerimod alfa is a potent monoclonal antibody *OX40* activator. Efizonerimod alfa can be used for cancer research .

HY-P99159

Ivuxolimab	Interleukin Related	Cancer
Ivuxolimab is a fully human IgG2 agonist targeting *OX40* (CD134), which selectively binds to the OX40 receptor on the surface of activated CD4 ⁺ and CD8 ⁺ T cells without inducing antibody-dependent cytotoxicity. Ivuxolimab can promote T cell proliferation, survival and cytokine (such as IFN-γ, IL-2) secretion, inhibit regulatory T cell function, and enhance anti-tumor immune response. Ivuxolimab can be used in the study of melanoma, hepatocellular carcinoma, head and neck squamous cell carcinoma, etc .

HY-151506

Phospholipid PL1	Liposome	Cancer
Phospholipid PL1 is a phospholipid-derived nanoparticle, can deliver costimulatory receptor mRNA (CD137 or OX40) to T cells. Phospholipid PL1 could induce the activation of various immune cells, including T cells and dendritic cells (DCs) in order to boost antitumor immunity .

HY-P990919

Gimistotug	TNF Receptor	Inflammation/Immunology
HY-P990919 is an *TNFRSF4*-targeting IgG1κ type humanized antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001) .

HY-P991012

Nuvustotug HFB301001	TNF Receptor	Inflammation/Immunology
HY-P991012 is an *TNFRSF4*-targeting IgG1κ type human antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001) .

HY-P991529

AGEN-2373	TNF Receptor	Inflammation/Immunology Cancer
AGEN-2373 is a conditionally active agonist antibody targeting the co-stimulatory receptor CD137. GEN-2373 binds to CD137 without disruption of ligand binding. AGEN-2373 stimulates CD137 under receptor clustering conditions. AGEN-2373 can enhance T cell activity when combined with other checkpoint modulators (e.g. PD-1 antagonist and OX40 agonist). AGEN-2373 can be studied in research for human malignancies .

HY-162306

*GLP-1R agonist* 18**	GLP Receptor	Cancer
GLP-1R agonist 18 (example 117) is an agonist for GLP-1R with an EC₅₀ of 0.044 nM .

HY-149190

*GPR35 agonist* 5**	GPR35	Cancer
GPR35 agonist 5 (3,5-dinitro-bisphenol A; compound 6) is a weak GPR35 agonist. GPR35 agonist 5 arrests CHO-S cells at the G1/Gophase .

HY-162850

*DOR agonist* 2**	Opioid Receptor TNF Receptor NF-κB ERK	Neurological Disease Inflammation/Immunology
DOR agonist 2 (Compound 3) is a Delta Opioid Receptor agonist. DOR agonist 2 can inhibit the expression of TNF-α, prevent NF-κB transport to the nucleus, and activate the G protein-mediated ERK1/2 pathway. DOR agonist 2 can be used in the study of neurodegenerative diseases .

HY-158167

*AhR agonist* 5**	Aryl Hydrocarbon Receptor	Inflammation/Immunology
AhR agonist 5 is an AHR agonist (EC₅₀ = 6 nM). From patent WO2024061187A1, compound 5 .

HY-149781

*STING agonist-34*	STING	Cancer
STING agonist-34 (Compound 12L) is a potent STING agonist with an IC₅₀ value of 1.15 μM and an EC₅₀ of 0.38 μM in THP1 cells. STING agonist-34 could be used in cancer research .

HY-168585

*GLP-1R agonist* 26**	GLP Receptor	Metabolic Disease
GLP-1R agonist 26 (compound 1) is a glucagon-like peptide-1 receptor (GLP-1R) agonist with an EC₅₀ of <10 nM .

HY-150030

*CB1/2 agonist* 4**	Cannabinoid Receptor	Neurological Disease
CB1/2 agonist 4 is a full CB1 agonist and CB2 partial agonist with EC₅₀ values of 15.09 nM and 1.16 nM, respectively. CB1/2 agonist 4 also has hCB1 and hCB2 receptor affinities with K_i values of 1.1 nM and 4.2 nM, respectively. CB1/2 agonist 4 has a significant antinociceptive activity, and also can activate cannabinoid and TRPV1 receptor with values of IC₅₀ and EC₅₀ is 0.8 μM and 0.12 μM, respectively .

HY-143320

*STING agonist-17*	STING	Cancer
STING agonist-17 (compound 4a) is a potent STING agonist with an IC₅₀ value of 0.062 nM. STING agonist-17 has anti-cancer activity for tumor immunization .

HY-122737

*RORγt Inverse agonist* 8**	ROR	Inflammation/Immunology
RORγt Inverse agonist 8 is a potent, selective, orally bioavailable RORγt inverse agonist, with an IC₅₀ of 19 nM for human RORγt-LBD .

HY-157955

*TAAR1 agonist* 1**	Trace Amine-associated Receptor (TAAR)	Neurological Disease
TAAR1 agonist 1 (compound 6E) is a potent TAAR1 agonist with a potent TAAR1-Gs/Gq dual-pathway activation property. TAAR1 agonist 1 significantly alleviates MK-801-induced schizophrenia-like cognitive phenotypes .

HY-156830

*TGR5 Receptor Agonist* 4**	G protein-coupled Bile Acid Receptor 1	Metabolic Disease
TGR5 Receptor Agonist 4 is an agonist of Bile Acid Receptor (TGR5), with EC₅₀ for hTGR5 and mTGR5 of 2 nM and 3 nM, respectively. TGR5 Receptor Agonist 4 plays important roles in hypoglycemic and weight loss .

HY-161915

*GLP-1R agonist* 23**	GLP Receptor	Metabolic Disease
GLP-1R agonist 23 (Example 376) is a GLP-1R agonist with an EC₅₀ of 0.056 nM. GLP-1R agonist 23 can be used in diabetes research .

HY-157955A

*TAAR1 agonist* 1 hydrochloride**	Trace Amine-associated Receptor (TAAR)	Neurological Disease
TAAR1 agonist 1 hydrochloride (6e·HCl) is a novel G-protein-coupled receptor TAAR1 agonist. TAAR1 agonist 1 hydrochloride is used in the study of schizophrenia .

HY-145458A

*GLP-1 receptor agonist* 9 citrate**	GCGR	Metabolic Disease
GLP-1 receptor agonist 9 citrate is a GLP-1 receptor agonist .

HY-147055

*THR-β agonist* 5**	Thyroid Hormone Receptor	Metabolic Disease
THR-β agonist 5 (compound 54) is a potent THR-β agonist, with an EC₅₀ of <50 nM .

HY-175490

*RORγ inverse agonist* 2**	ROR	Inflammation/Immunology
RORγ inverse agonist 2 (Compound 15) is a potent inverse agonist of the retinoic acid receptor-related orphan receptor RORγ, with IC₅₀ values of 0.4 and 0.9 μM for Gal4-RORγ and full-length RORγ, respectively. RORγ inverse agonist 2 is useful in the study of autoimmune diseases .

HY-161265

*HIF-2α agonist* 3**	HIF/HIF Prolyl-Hydroxylase	Metabolic Disease
HIF-2α agonist 3 (Compound 14d) is an orally active HIF-2α agonist with a EC₅₀ value of 1.78 μM. HIF-2α agonist 3 can be used in the study of renal anemia .

HY-168051

*TLX agonist* 2**	Orphan Receptor	Neurological Disease Cancer
TLX agonist 2 (compound 31) is a TLX agonist (EC₅₀=0.1 μM; K_d=0.16 μM). TLX agonist 2 promotes TLX transcriptional activity and enhances the expression of TLX target genes by binding to TLX. TLX agonist 2 can be used in the study of neurodegenerative diseases .

HY-149644

*CB2R agonist* 3**	Cannabinoid Receptor	Inflammation/Immunology
CB2R agonist 3 is an agonist of cannabinoid receptor 2 (CB2R), with EC₅₀ of 0.37μM that plays an important role in immune system .

HY-130797

*TLR7/8 agonist* 3**	Toll-like Receptor (TLR)	Cancer
TLR7/8 agonist 3 (Compound II) is a potent TLR7 and TLR8 agonist, extracted from patent WO2016057618 (compound of formula (II)) .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N2548

Turkesterone	Cardiovascular Disease Structural Classification other families Classification of Application Fields Source classification Plants Disease Research Fields Steroids	Others
Turkesterone is a potent ecdysteroid. Turkesterone acts as an ecdysteroid receptor (EcR) agonist in some insect systems .

HY-W341997

9-Octadecynoic acid	Structural Classification Leguminosae Paramacrolobium coeruleum (Taub.) J.Léonard Ketones, Aldehydes, Acids Source classification Plants	PPAR
9-Octadecynoic acid is a DNA binding agent with a dissociation constant of 1.8 mM. 9-Octadecynoic acid is also an agonist for peroxisome proliferator-activated receptor γ (PPARγ) .

HY-14608

L-Glutamic acid 10+ Cited Publications	Structural Classification Microorganisms Source classification Disease markers Endocrine diseases Amino acids Nervous System Disorder Endogenous metabolite Cardiovascular System Disorder Cancer	Endogenous Metabolite iGluR Ferroptosis Apoptosis
L-Glutamic acid is an excitatory amino acid neurotransmitter that acts as an agonist for all subtypes of glutamate receptors (metabolic rhodophylline, NMDA, and AMPA). L-Glutamic acid has an agonist effect on the release of DA from dopaminergic nerve endings. L-Glutamic acid can be used in the study of neurological diseases. L-Glutamic acid acts at ionotropic and metabotropic glutamate receptors ^[4] .

HY-14608A

L-Glutamic acid monosodium salt 10+ Cited Publications	Structural Classification Microorganisms other families Animals Source classification Amino acids Plants	iGluR Apoptosis Ferroptosis Endogenous Metabolite
L-Glutamic acid monosodium salt is an excitatory amino acid neurotransmitter that acts as an agonist for all subtypes of glutamate receptors (metabolic rhodophylline, NMDA, and AMPA). L-Glutamic acid monosodium salt has an agonist effect on the release of DA from dopaminergic nerve endings. L-Glutamic acid monosodium salt can be used in the study of neurological diseases. L-Glutamic acid monosodium salt acts at ionotropic and metabotropic glutamate receptors ^[4] .

HY-114364

UDP-Galactose disodium 1 Publications Verification	Structural Classification Natural Products Neurological Disease Classification of Application Fields Source classification Endogenous metabolite Disease Research Fields	P2Y Receptor Endogenous Metabolite
UDP-Galactose disodium is a natural agonist of the P2Y₁₄ receptor with an EC₅₀ of 0.67 μM for the hP2Y₁₄ receptor. UDP-Galactose disodium is a substrate for the transferase beta-1, 4 galactosyltransferase V (B4GALT5). In addition, UDP-Galactose disodium is required for the biosynthesis of several abundant glycoconjugates that form the surface glycocalyx of Leishmania major .

HY-N7624

Methyl oleanonate 3-OXoolean-12-en-28-oic acid methyl ester	Triterpenes Pistacia lentiscus var. Chia other families Classification of Application Fields Terpenoids Source classification Plants Disease Research Fields Cancer Anacardiaceae	PPAR
Methyl oleanonate is a natural triterpene PPARγ agonist isolated from the species of Pistacia lentiscus var. Chia . Methyl oleanonate is a modified oleanolic acid derivative with anti-cancer effects .

HY-Y0511

N,N-Dimethylglycine 1 Publications Verification Dimethylglycine; DMG; N-Methylsarcosine	Structural Classification Microorganisms Other disease Classification of Application Fields Source classification Disease markers Other Diseases Amino acids Endogenous metabolite Disease Research Fields	Endogenous Metabolite iGluR Amino Acid Derivatives
N,N-Dimethylglycine (Dimethylglycine), a natural N-methylated glycine, is a nutrient supplement and acts as an NMDAR glycine site partial agonist. N,N-Dimethylglycine is a methyl donor that can improve immunity, act as an antioxidant to prevent oxidative stress, and scavenge excess free radicals. N,N-Dimethylglycine has antidepressant-like and surfactant effects .

HY-N3377

Liriodendrin	Structural Classification Natural Products Eucommia ulmoides Oliver Source classification Eucommiaceae Plants	HSP
Liriodendrin is an HSF1 agonist can be isolated from E. ulmoides .

HY-N2548R

Turkesterone (Standard)	Structural Classification other families Source classification Plants Steroids	Reference Standards Others
Turkesterone (Standard) is the analytical standard of Turkesterone. This product is intended for research and analytical applications. Turkesterone is a potent ecdysteroid. Turkesterone acts as an ecdysteroid receptor (EcR) agonist in some insect systems .

HY-14608AR

L-Glutamic acid monosodium salt (Standard)	Structural Classification Microorganisms other families Animals Source classification Amino acids Plants	Reference Standards iGluR Apoptosis Ferroptosis Endogenous Metabolite
L-Glutamic acid (monosodium salt) (Standard) is the analytical standard of L-Glutamic acid (monosodium salt). This product is intended for research and analytical applications. L-Glutamic acid monosodium salt is an excitatory amino acid neurotransmitter that acts as an agonist for all subtypes of glutamate receptors (metabolic rhodophylline, NMDA, and AMPA). L-Glutamic acid monosodium salt has an agonist effect on the release of DA from dopaminergic nerve endings. L-Glutamic acid monosodium salt can be used in the study of neurological diseases ^[4] .

HY-N16024

FP-20 sodium	Structural Classification Lipid	Toll-like Receptor (TLR)
FP-20 sodium, a selective *TLR4* agonist, is a vaccine adjuvant. FP-20 sodium induces MAPK- and NLRP3-dependent inflammasome activation. FP20 shows no toxicity in mouse vaccination experiments with OVA antigen and induces IgG production .

HY-N0234

Bavachinin 5 Publications Verification 7-O-Methylbavachin; Bavachinin A	Structural Classification Monophenols Flavonoids Classification of Application Fields Leguminosae Flavonones Source classification Phenols Psoralea corylifolia L. Plants Inflammation/Immunology Disease Research Fields	Amyloid-β PPAR HIF/HIF Prolyl-Hydroxylase
Bavachinin is agonist of pan-peroxisome proliferator-activated receptor (PPAR), with the IC₅₀ value of 21.043 μM, 12.819 μM, and 0.622 μM to PPAR-α, RRAR-β/δ, and PPAR-γ, respectively. Bavachinin is an inhibitor of HIF-1α. Bavachinin exhibits antitumor activity against non-small cell lung cancer by targeting RRAR-γ. Bavachinin is a natural compound with anti-inflammatory and anti-angiogenic activities. Bavachinin has orally bioactivity. ^[4] .

HY-N0234R

Bavachinin (Standard) 7-O-Methylbavachin (Standard); Bavachinin A (Standard)	Structural Classification Monophenols Flavonoids Leguminosae Flavonones Source classification Phenols Psoralea corylifolia L. Plants	Amyloid-β Reference Standards PPAR HIF/HIF Prolyl-Hydroxylase
Bavachinin (Standard) is the analytical standard of Bavachinin. This product is intended for research and analytical applications. Bavachinin is agonist of pan-peroxisome proliferator-activated receptor (PPAR), with the IC₅₀ value of 21.043 μM, 12.819 μM, and 0.622 μM to PPAR-α, RRAR-β/δ, and PPAR-γ, respectively. Bavachinin is an inhibitor of HIF-1α. Bavachinin exhibits antitumor activity against non-small cell lung cancer by targeting RRAR-γ. Bavachinin is a natural compound with anti-inflammatory and anti-angiogenic activities. Bavachinin has orally bioactivity. ^[4] .

HY-14608R

L-Glutamic acid (Standard)	Structural Classification Microorganisms Source classification Disease markers Endocrine diseases Amino acids Nervous System Disorder Endogenous metabolite Cardiovascular System Disorder Cancer	Reference Standards Endogenous Metabolite iGluR Ferroptosis Apoptosis
L-Glutamic acid (Standard) is the analytical standard of L-Glutamic acid. This product is intended for research and analytical applications. L-Glutamic acid is an excitatory amino acid neurotransmitter that acts as an agonist for all subtypes of glutamate receptors (metabolic rhodophylline, NMDA, and AMPA). L-Glutamic acid has an agonist effect on the release of DA from dopaminergic nerve endings. L-Glutamic acid can be used in the study of neurological diseases ^[4] . IC₅₀ & Target:DA . In Vitro: L-Glutamic acid (120, 500, 750, 1000 mg/dL) can reduce the harmful effect of lithium on the embryonic development of Xenopus Xenopus . L-Glutamic acid (2, 5, 10, 20 mM, 24-48 h) can induce neuroexcitotoxicity in neuroblastoma ^[4]. In Vivo: L-Glutamic acid (3 g/kg, subcutaneous injection) can promote excitotoxic degeneration of retinal ganglion cells in mice . L-Glutamic acid (750 mg/kg, intraperitoneal injection) can reduce and inhibit oxidative stress induced by chlorpyrifos (CPF) in rats .

HY-B1021

Vincamine 1 Publications Verification	Apocynaceae Cardiovascular Disease Alkaloids Structural Classification Classification of Application Fields Source classification Plants Disease Research Fields Indole Alkaloids Catharanthus roseus (L.) G. Don	Free Fatty Acid Receptor
Vincamine is a monoterpenoid indole alkaloid extracted from the Madagascar periwinkle. Vincamine is a peripheral vasodilator and exerts a selective vasoregulator action on the brain microcapilar circulation . Vincamine is a GPR40* agonist* and acts as a β-cell protector by ameliorating β-cell dysfunction and promoting glucose-stimulated insulin secretion (GSIS). Vincamine improves glucose homeostasis in vivo, and has the potential for the type 2 diabetes mellitus (T2DM) research .

HY-B1021R

Vincamine (Standard)	Apocynaceae Alkaloids Structural Classification Source classification Plants Indole Alkaloids Catharanthus roseus (L.) G. Don	Reference Standards Free Fatty Acid Receptor
Vincamine (Standard) is the analytical standard of Vincamine. This product is intended for research and analytical applications. Vincamine is a monoterpenoid indole alkaloid extracted from the Madagascar periwinkle. Vincamine is a peripheral vasodilator and exerts a selective vasoregulator action on the brain microcapilar circulation . Vincamine is a GPR40* agonist* and acts as a β-cell protector by ameliorating β-cell dysfunction and promoting glucose-stimulated insulin secretion (GSIS). Vincamine improves glucose homeostasis in vivo, and has the potential for the type 2 diabetes mellitus (T2DM) research .

HY-17038A

Agomelatine hydrochloride 4 Publications Verification S-20098 hydrochloride	Structural Classification Alkaloids Neurological Disease Classification of Application Fields Other Alkaloids Source classification Endogenous metabolite Disease Research Fields	Melatonin Receptor 5-HT Receptor Endogenous Metabolite
Agomelatine hydrochloride (S-20098 hydrochloride) is a specific agonist of MT1 and MT2 receptors with K_is of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively . Agomelatine hydrochloride is a selective 5-HT2C receptor antagonist with pK_is of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively .

HY-17038

Agomelatine 4 Publications Verification S-20098	Structural Classification Alkaloids Neurological Disease Classification of Application Fields Other Alkaloids Source classification Endogenous metabolite Disease Research Fields	Melatonin Receptor 5-HT Receptor Endogenous Metabolite
Agomelatine (S-20098) is a specific agonist of MT1 and MT2 receptors with K_is of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively . Agomelatine is a selective 5-HT2C receptor antagonist with pK_is of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively .

HY-113037

(E/Z)-Farnesyl pyrophosphate (E/Z)-Farnesyl diphosphate	Structural Classification Natural Products Human Gut Microbiota Metabolites Microorganisms Neurological Disease Classification of Application Fields Source classification Endogenous metabolite Disease Research Fields	TRP Channel Endogenous Metabolite
(E/Z)-Farnesyl pyrophosphate ((E/Z)-Farnesyl diphosphate), a 15-carbon isoprenoid, is a metabolic intermediate of the mevalonate (MVA) pathway. (E/Z)-Farnesyl pyrophosphate is a TRPM2 (TRP Channel) agonist, activates TRPM2 opening for ion influx. (E/Z)-Farnesyl pyrophosphate is a key branch substrate for cholesterol synthesis, ubiquinones synthesis, protein farnesylation decoration, and geranyl-geranyl pyrophosphate (GGPP) synthesis .

HY-17038B

Agomelatine (L(+)-Tartaric acid) 4 Publications Verification S-20098 L(+)-Tartaric acid	Structural Classification Alkaloids Neurological Disease Classification of Application Fields Other Alkaloids Source classification Endogenous metabolite Disease Research Fields	Melatonin Receptor 5-HT Receptor Endogenous Metabolite
Agomelatine L(+)-Tartaric acid (S-20098 L(+)-Tartaric acid) is a specific agonist of MT1 and MT2 receptors with K_is of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively . Agomelatine L(+)-Tartaric acid is a selective 5-HT2C receptor antagonist with pK_is of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively .

HY-17038R

Agomelatine (Standard) S-20098 (Standard)	Structural Classification Alkaloids Other Alkaloids Source classification Endogenous metabolite	Reference Standards Melatonin Receptor 5-HT Receptor Endogenous Metabolite
Agomelatine (Standard) is the analytical standard of Agomelatine. This product is intended for research and analytical applications. Agomelatine (S-20098) is a specific agonist of MT1 and MT2 receptors with K_is of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively . Agomelatine is a selective 5-HT2C receptor antagonist with pK_is of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively .

HY-17038AR

Agomelatine hydrochloride (Standard)	Structural Classification Alkaloids Other Alkaloids Source classification Endogenous metabolite	Melatonin Receptor 5-HT Receptor Endogenous Metabolite
Agomelatine (hydrochloride) (Standard) is the analytical standard of Agomelatine (hydrochloride). This product is intended for research and analytical applications. Agomelatine hydrochloride (S-20098 hydrochloride) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively . Agomelatine hydrochloride is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively .

HY-113246

15-keto-Prostaglandin F2a 15-keto-PGF2α	Structural Classification Classification of Application Fields Ketones, Aldehydes, Acids Source classification Endogenous metabolite Disease Research Fields Endocrinology	Prostaglandin Receptor Endogenous Metabolite
15-keto-Prostaglandin F2α (15-keto-PGF2α) is a metabolite of Prostaglandin F2α. Prostaglandin F2α. Prostaglandin F2α is an orally active, potent prostaglandin F (PGF) receptor (FP receptor) agonist and plays a key role in the onset and progression of labour .

HY-N3216

Nagilactone B	Other Terpenoids Cardiovascular Disease Structural Classification Podocarpus nagi Classification of Application Fields Terpenoids Source classification Podocarpaceae Plants Disease Research Fields	LXR
Nagilactone B is a liver X receptor (LXR) agonist.

HY-N3209

Nelumol A	Structural Classification Ketones, Aldehydes, Acids Source classification Ligularia nelumbifolia (Bur. et Franch.) Hand.-Mazz. Plants Compositae	FXR
Nelumol A is a farnesoid X receptor (FXR) agonist .

HY-N1415

β-Caryophyllene 3 Publications Verification (-)-(E)-Caryophyllene; (−)-β-caryophyllene; (−)-trans-Caryophyllene	Structural Classification Neurological Disease Classification of Application Fields Anti-aging Source classification Plants Endogenous metabolite Infection other families Terpenoids Sesquiterpenes Disease Research Fields Cancer	Cannabinoid Receptor Endogenous Metabolite
β-Caryophyllene is a CB2 receptor agonist.

HY-113308A

Taurolithocholic acid sodium salt 5 Publications Verification	Structural Classification Animals Classification of Application Fields Source classification Metabolic Disease Disease Research Fields Steroids	Calcium Channel Endogenous Metabolite
Taurolithocholic acid sodium salt, a potent cholestatic agent, is a potent Ca ²⁺ agonist .

HY-103273

Muristerone A	Structural Classification Ipomoea nil (Linnaeus) Roth Classification of Application Fields Source classification Other Diseases Plants Convolvulaceae Disease Research Fields Steroids	Endogenous Metabolite
Muristerone A is a phytoecdysteroid analog of ecdysone and a potent agonist of ecdysteroid receptor with a K_d of 1 nM .

HY-N12093

Cevadine	Structural Classification Alkaloids Other Alkaloids Source classification Veratrum oblongum Loes. Plants Melanthiaceae	Sodium Channel Parasite
Cevadine is a voltage-sensitive sodium channel agonist. Cevadine has insecticidal activity .

HY-W015326

3-Hydroxymandelic Acid	Monophenols Classification of Application Fields Ketones, Aldehydes, Acids Source classification Other Diseases Phenols Endogenous metabolite Disease Research Fields	Endogenous Metabolite
3-Hydroxymandelic Acid, a metabolite of Phenylephrine, Phenylephrine is a α-receptor agonist.

HY-50290A

Meluadrine tartrate	Structural Classification Monophenols Classification of Application Fields Source classification Other Diseases Phenols Endogenous metabolite Disease Research Fields	Endogenous Metabolite Adrenergic Receptor
Meluadrine tartrate is a potent agonist of β2 adrenergic receptor .

HY-N10123

Indolokine A5	Alkaloids Classification of Application Fields Source classification Endogenous metabolite Disease Research Fields Indole Alkaloids Cancer	Aryl Hydrocarbon Receptor
Indolokine A5, a catabolite of L-cysteine, is a potent AhR agonist .

HY-115762

4-Hydroxytryptamine creatinine sulfate	Structural Classification Alkaloids Neurological Disease Classification of Application Fields Source classification Endogenous metabolite Disease Research Fields Indole Alkaloids	Endogenous Metabolite
4-Hydroxytryptamine creatinine sulfate, a tryptamine derivative, is a neurotransmitter agonist .

HY-N16013

FP-18 disodium	Structural Classification Lipid	Toll-like Receptor (TLR)
FP-18 disodium, a *TLR-4* agonist, is a vaccine adjuvant.

HY-N0175

Cytisinicline 1 Publications Verification Cytisine; Sophorine; BaptitOXine	Alkaloids Structural Classification Classification of Application Fields Leguminosae Source classification Pyridine Alkaloids Metabolic Disease Plants Thermopsis lanceolala R.Br. Disease Research Fields	nAChR
Cytisinicline (Cytisine) is an alkaloid. Cytisinicline (Cytisine) is a partial agonist of α4β2 nAChRs , and partial to full agonist at β4 containing receptors and α7 receptors . Has been used medically to help with smoking cessation .

HY-N16020

α-Glucosyl FP20 sodium	Structural Classification Lipid	Toll-like Receptor (TLR)
α-Glucosyl FP20 sodium, a *TLR-4* agonist, is a vaccine adjuvant.

HY-N15893

α-Galactosyl FP20 sodium	Structural Classification Lipid	Toll-like Receptor (TLR)
α-Galactosyl FP20 sodium, a *TLR-4* agonist, is a vaccine adjuvant.

HY-N3891

Fargesone A	Structural Classification Source classification Magnoliaceae Lignans Yulania biondii (Pamp.) D. L. Fu Phenylpropanoids Plants	FXR
Fargesone A is a potent and selective FXR agonist. Fargesone A shows anti-inflammatory activity .

HY-N16009

α-Rhamnosyl FP20 sodium	Structural Classification Lipid	Toll-like Receptor (TLR)
α-Rhamnosyl FP20 sodium, a *TLR-4* agonist, is a vaccine adjuvant.

HY-79593

MRE-269 1 Publications Verification ACT-333679	Structural Classification Classification of Application Fields Ketones, Aldehydes, Acids Source classification Endogenous metabolite Disease Research Fields Endocrinology	Prostaglandin Receptor
MRE-269 is an active metabolite of selexipag, and acts as a selective IP receptor agonist.

HY-N2333

Resiniferatoxin 5 Publications Verification (+)-ResiniferatOXin	Cardiovascular Disease Euphorbia resinifera O. Berg Classification of Application Fields Source classification Euphorbiaceae Plants Disease Research Fields	TRP Channel
Resiniferatoxin ((+)-Resiniferatoxin), is a selective agonist of transient receptor potential vanilloid 1 (TRPV1) receptor agonist. Resiniferatoxin can be isolated from the Euphorbia resinifera plant. Resiniferatoxin eliminates TRPV1+ primary sensory afferents and blunt cardiac sympathetic afferent reflex for a relatively long period .

HY-W014666

Xanthurenic acid 2 Publications Verification	Structural Classification Monophenols Immune System Disorder Microorganisms Ketones, Aldehydes, Acids Disease markers Phenols Endocrine diseases Endogenous metabolite	Endogenous Metabolite mGluR Apoptosis
Xanthurenic acid is a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus.

HY-N6629

3'-Methoxyflavonol	Flavonols Structural Classification Flavonoids Microorganisms Source classification	Neuromedin U Receptor (NMUR)
3'-Methoxyflavonol is a selective agonist of neuromedin U 2 receptor (NMU2R).

HY-104026

L-Kynurenine 20+ Cited Publications	Cardiovascular Disease Structural Classification Human Gut Microbiota Metabolites Neurological Disease Classification of Application Fields Ketones, Aldehydes, Acids Endogenous metabolite Inflammation/Immunology Disease Research Fields	Aryl Hydrocarbon Receptor Endogenous Metabolite
L-Kynurenine is a metabolite of the amino acid L-tryptophan. L-Kynurenine is an aryl hydrocarbon receptor agonist.

HY-N0178

Diosmin 10+ Cited Publications	Cardiovascular Disease Structural Classification Flavonoids Classification of Application Fields Flavones Source classification Rutaceae Plants Citrus Disease Research Fields	Aryl Hydrocarbon Receptor
Diosmin is a flavonoid found in a variety of citrus fruits and also an agonist of the aryl hydrocarbon receptor (AhR).

HY-10002

Calcitriol 60+ Cited Publications 1,25-DihydrOXyvitamin D3	Structural Classification Natural Products Classification of Application Fields Source classification Endogenous metabolite Disease Research Fields Cancer	Drug Metabolite VD/VDR Endogenous Metabolite
Calcitriol is the most active metabolite of vitamin D and also a vitamin D receptor (VDR) agonist.

HY-B0188A

Mianserin hydrochloride 1 Publications Verification Org GB 94	Alkaloids Structural Classification Neurological Disease Classification of Application Fields Leguminosae Other Alkaloids Source classification Crotalaria pallida Ait. Plants Disease Research Fields Endocrinology	Histamine Receptor
Mianserin hydrochloride (Org GB 94) is a H1 receptor inverse agonist and is a psychoactive agent of the tetracyclic antidepressant.

HY-N16231

3A-MPLA ammonium	Structural Classification Lipid	Toll-like Receptor (TLR)
3A-MPLA ammonium, a monophosphoryl rri-acyl lipid A, is a TLR-4 agonist .

HY-N9333

Wistin	Flavonoids other families Classification of Application Fields Source classification Metabolic Disease Plants Disease Research Fields Isoflavones	PPAR
Wistin, isolated from Caragana sinica roots, is a PPARα and PPARγ agonist .

HY-N3398

Lauroscholtzine N-Methyllaurotetanine	Alkaloids Structural Classification Thalictrum revolutum DC. Ranunculaceae Source classification Plants Isoquinoline Alkaloids	5-HT Receptor
Lauroscholtzine (N-Methyllaurotetanine), a natural alkaloid, is a 5-HT1A receptor agonist .

Cat. No.	Product Name	Chemical Structure

HY-15394S1

(Rac)-Rotigotine-d3 hydrochloride

(Rac)-Rotigotine-d₃ hydrochloride is a deuterium labeled (Rac)-Rotigotine (hydrochloride) (HY-15394). (Rac)-Rotigotine hydrochloride is a racemate of Rotigotine. Rotigotine is a full agonist of dopamine receptor, a partial agonist of the 5-HT1A receptor, and an antagonist of the α2B-adrenergic receptor, with K_is of 0.71 nM, 4-15 nM, and 83 nM for the dopamine D3 receptor and D2, D5, D4 receptors, and dopamine D1 receptor.

HY-10019AS1

Varenicline-d4 hydrochloride

Varenicline-d₄ hydrochloride is a deuterium labeled Varenicline (dihydrochloride) (HY-10019A) . Varenicline (CP 526555) dihydrochloride is a potent partial agonist for α4β2 nicotinic acetylcholine receptor (nAChR) with an EC₅₀ value of 2.3 μM. Varenicline dihydrochloride is a full agonist for α3β4 and α7 nAChRs with EC₅₀ values of 55 μM and 18 μM, respectively . Varenicline dihydrochloride is a nicotinic ligand based on the structure of cytosine, and has the potential for smoking cessation treatment .

HY-135119

Salmeterol-d3
Salmeterol-d₃ is a deuterium labeled Salmeterol. Salmeterol is a potent and selective human β2 adrenoceptor agonist. Salmeterol shows potent stimulation of cAMP accumulation in CHO cells expressing human β2, β1 and β3 adrenoceptors with pEC₅₀s of 9.6, 6.1, and 5.9, respectively .

HY-P0090S

Calcitonin-13C6,15N4 (salmon) TFA
Calcitonin- ¹³C₆, ¹⁵N₄ (salmon) (Salmon calcitonin- ¹³C₆, ¹⁵N₄) TFA is ¹³C and ¹⁵N-labeled Calcitonin (salmon) (HY-P0090). Calcitonin (salmon) , a calcium regulating hormone, is a dual-action amylin and calcitonin receptor agonist, could stimulate bone formation and inhibit bone resorption .

HY-160266

*THR-β agonist* 7**
THR-β agonist-1 (Example 2) is a THR-β agonist, with EC₅₀ values of 52 nM and 1017 nM for THR-β and THR-α, respectively .

HY-172836S

*GLP-1 receptor agonist* 17-d3**
GLP-1 receptor agonist 17-d3 (Compound 701) is the deuterium labeled GLP-1R agonist 17 (HY-148212). GLP-1R agonist 17 is a GLP-1 receptor agonist that can be used for the research of cardiovascular metabolic diseases .

HY-169332

*Piezo1 agonist* 1-d2**
Piezo1 agonist 1-d₂ (Compound 12a) is an agonist for Piezo1 with an EC₅₀ of 2.21 μM. Piezo1 agonist 1-d₂ activates the Ca ²⁺-related ERK signaling pathway, and thus promotes the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs). Piezo1 agonist 1-d₂ ameliorates disuse osteoporosis in the hindlimb-unloading (HU) rat model .

HY-10019S1

Varenicline-15N,13C,d2

Varenicline- ¹⁵N, ¹³C,d₂ is ¹⁵N and deuterated labeled Varenicline (HY-10019). Varenicline (CP 526555) is an orally active partial agonist of α4β2 nicotinic acetylcholine receptor (α4β2 nAChR, IC₅₀=250 nM), which is the principal mediator of nicotine dependence. Varenicline is also a partial agonist of α6β2 nAChR and a full agonist of α7β2 nAChR. Varenicline blocks the direct agonist effects of nicotine on nAChR while stimulates nAChR in a more moderate way, being widely used as an aid of smoking cessation ^[4] .

HY-B0121BS2

Sumatriptan-d5
Sumatriptan-d₅ is deuterated labeled Sumatriptan (HY-B0121B). Sumatriptan (GR 43175) is an orally active 5-HT1 receptor agonist with IC₅₀s of 7.3 nm, 9.3nm and 17.8 nm for 5-HT_1D, 5-HT_1B and 5-HT_1F receptors, respectively. Sumatriptan can be used for migraine headache research ^[4].

HY-131105S

Cimbuterol-d9
Cimbuterol-d₉ is the deuterium labeled Cimbuterol (HY-131105). Cimbuterol is a β-adrenergic agonist. β-adrenergic agonists act as bronchodilators and tocolytics. β-adrenergic agonists promote growth .

HY-104026S

L-Kynurenine-d4
L-Kynurenine-d₄ is the deuterium labeled L-Kynurenine. L-Kynurenine is a metabolite of the amino acid L-tryptophan. L-Kynurenine is an aryl hydrocarbon receptor agonist[1][2].

HY-B0349S

Meclizine-d8
Meclizine-d₈ is a deuterium labeled Meclizine. Meclizine is a histamine H1 receptor antagonist and has the potential to treat nausea and motion sickness. Meclizine is an agonist ligand for mouse constitutive androstane receptor (CAR) and an inverse agonist for Human CAR .

HY-10019S2

Varenicline-13C15N

Varenicline- ¹³C ¹⁵N (CP 526555- ¹³C ¹⁵N) is ¹³C and ¹⁵N labeled Varenicline. Varenicline (CP 526555) is an orally active partial agonist of α4β2 nicotinic acetylcholine receptor (α4β2 nAChR, IC₅₀ = 250 nM), which is the principal mediator of nicotine dependence. Varenicline is also a partial agonist of α6β2 nAChR and a full agonist of α7β2 nAChR. Varenicline blocks the direct agonist effects of nicotine on nAChR while stimulates nAChR in a more moderate way, being widely used as an aid of smoking cessation ^[4] .

HY-10020S

Varenicline-15N3 hydrochloride

Varenicline-15N3 Hydrochloride (CP 526555-15N3 Hydrochloride) is the ¹⁵N labeled isotope of Varenicline hydrochloride (HY-10020). Varenicline (CP 526555) is an orally active partial agonist of α4β2 nicotinic acetylcholine receptor (α4β2 nAChR, IC₅₀ = 250 nM), which is the principal mediator of nicotine dependence. Varenicline is also a partial agonist of α6β2 nAChR and a full agonist of α6β2 nAChR. Varenicline blocks the direct agonist effects of nicotine on nAChR while stimulates nAChR in a more moderate way, being widely used as an aid of smoking cessation ^[4] .

HY-14728S

Deutaleglitazar
Deutaleglitazar is a agonist of dual peroxisome proliferatory activating receptor (PPARα and PPARγ) .

HY-B1540S

Beclomethasone-d5
Beclomethasone-d₅ is the deuterium labeled Beclometasone. Beclometasone (Beclomethasone) is a prototype glucocorticoid receptor agonist.

HY-131104S

Brombuterol-d9
Brombuterol-d₉ is a deuterium labeled Brombuterol. Brombuterol is a β-adrenergic receptor agonist .

HY-157502S

Buctopamine-d9
Buctopamine-d9 is the deuterium labeled Buctopamine. Buctopamine is a β2 adrenoceptor agonist .

HY-B0418AS

Loperamide-d6 hydrochloride
Loperamide-d₆ (hydrochloride) is a deuterium labeled Loperamide hydrochloride. Loperamide hydrochloride is an opioid receptor agonist for the treatment of diarrhea .

HY-B0823S

Acetamiprid-d3
Acetamiprid-d₃ is the deuterium labeled Acetamiprid. Acetamiprid is a neonicotinoid insecticide. Acetamiprid is a nAChR agonist .

HY-12721S

Clonidine-d4 hydrochloride
Clonidine-d₄ (hydrochloride) is the deuterium labeled Clonidine. Clonidine hydrochloride is an alpha 2-adrenergic agonist .

HY-131104AS

Brombuterol-d9 hydrochloride
Brombuterol-d₉ (hydrochloride) is a deuterium labeled Brombuterol hydrochloride. Brombuterol hydrochloride is a β-adrenergic receptor agonist .

HY-115766S

Anabaseine-d4
Anabaseine-d₄ is the deuterium labeled Anabaseine (HY-115766). Anabaseine is a non-selective nicotinic agonist. Anabaseine stimulates all AChRs, preferentially stimulates skeletal muscle and brain α7 subtypes . Anabaseine is also a weak partial agonist at α4β2 nAChRs .

HY-Y1176S

Isonipecotic acid-d9
Isonipecotic acid-d₉ is the deuterium labeled Isonipecotic acid . Isonipecotic acid is a GABAA receptor partial agonist .

HY-17038S

Agomelatine-d6
Agomelatine-d₆ is deuterium labeled Agomelatine. Agomelatine is a specific agonist of MT1 and MT2 receptors .

HY-B0189S1

Mosapride-d5
Mosapride-d₅ is the deuterium labeled Mosapride. Mosapride is a gastroprokinetic agent that acts as a selective 5HT4 agonist.

HY-W743727

Cytisine-d4
Cytisine-d₄ is the deuterium labeled Cytisinicline (HY-N0175). Cytisinicline (Cytisine) is an alkaloid. Cytisinicline (Cytisine) is a partial agonist of α4β2 nAChRs , and partial to full agonist at β4 containing receptors and α7 receptors . Has been used medically to help with smoking cessation .

HY-172439S

Simedeutirom
Simedeutirom is the agonist for thyroid hormone beta receptor (THRβ) and can be used for researchs of metabolic diseases, such as obesity and diabetes mellitus .

HY-113308AS

Taurolithocholic acid-d4 sodium
Taurolithocholic acid-d₄ (sodium) is the deuterium labeled Taurolithocholic acid (sodium salt). Taurolithocholic acid sodium salt, a potent cholestatic agent, is a potent Ca2+ agonist .

HY-100699S

Clenproperol-d7
Clenproperol-d₇ is the deuterium labeled Clenproperol. Clenproperol is a β2-adrenergic agonist .

HY-A0007S

Rotigotine-d7 hydrochloride
Rotigotine-d₇ (hydrochloride) is the deuterium labeled Rotigotine(N-0923), which is a dopamine D2 and D3 receptor agonist.

HY-N6807S

Elemicin-d3
Elemicin-d₃ is deuterated labeled Pemafibrate (HY-17618). Pemafibrate is a highly selective PPARα agonist, with an EC₅₀ of 1 nM.

HY-B0452S1

Ritodrine-d3 hydrochloride
Ritodrine-d₃ (hydrochloride) is the deuterium labeled Ritodrine (hydrochloride). Ritodrine hydrochloride (DU21220 hydrochloride) is a β-2 adrenergic receptor agonist.

HY-17618S

Pemafibrate-d4
Pemafibrate-d₄ is deuterated labeled Pemafibrate (HY-17618). Pemafibrate is a highly selective PPARα agonist, with an EC₅₀ of 1 nM.

HY-113308AS2

Taurolithocholic acid-d4-1 sodium
Taurolithocholic acid-d₄-1 (sodium) is the deuterium labeled Taurolithocholic acid. Taurolithocholic acid sodium salt, a potent cholestatic agent, is a potent Ca2+ agonist .

HY-13338S

Mabuterol-d9
Mabuterol-d₉ is a deuterium labeled Mabuterol. Mabuterol is an agonist of the β2-adrenergic receptor .

HY-B0648S

Medroxyprogesterone-d3
Medroxyprogesterone-d₃ is the deuterium labeled Medroxyprogesterone. Medroxyprogesterone is a progestin, a synthetic variant of the human hormone progesterone and a potent progesterone receptor agonist.

HY-17034BS

Medetomidine-d3 hydrochloride
Medetomidine-d₃ (hydrochloride) is the deuterium labeled Medetomidine hydrochloride. Medetomidine hydrochloride is an agonist of adrenergic alpha-2 receptor .

HY-N1415S

β-Caryophyllene-d2
β-Caryophyllene-d₂ is deuterium labeled β-Caryophyllene. β-Caryophyllene is a CB2 receptor agonist.

HY-113308AS1

Taurolithocholic Acid-d5 sodium salt
Taurolithocholic Acid-d₅ (sodium) is the deuterium labeled Taurolithocholic acid sodium salt. Taurolithocholic acid sodium salt, a potent cholestatic agent, is a potent Ca2+ agonist .

HY-A0072S

Zilpaterol-d7
Zilpaterol-d₇ is a deuterium Zilpaterol. Zilpaterol is a β-adrenergic agonist that have been widely used to feed cattle .

HY-17030S

Acamprosate-d3 calcium
Acamprosate-d₃ (calcium) is the deuterium labeled Acamprosate calcium. Acamprosate calcium is a GABA receptor agonist and modulator of glutamatergic systems .

HY-136435S1

Mapenterol-d6 hydrochloride
Mapenterol-d₆ (hydrochloride) is the deuterium labeled Mapenterol hydrochloride. Mapenterol hydrochloride is a type of β2-adrenoceptor agonist .

HY-110233S

Acamprosate-d6 calcium
Acamprosate-d₆ (calcium) is the deuterium labeled Acamprosate calcium. Acamprosate calcium (Campral EC) is a GABA receptor agonist and modulator of glutamatergic systems .

HY-U00315S

Gidazepam-d5
Gidazepam-d5 is a deuterium labeled Gidazepam. Gidazepam is an agonist of GABA receptor channels (GABA RCs), and has anticonvulsant effect .

HY-19883S

Lusutrombopag-d13
Lusutrombopag-d₁₃ is deuterium labeled Lusutrombopag. Lusutrombopag is an orally bioavailable thrombopoietin (TPO) receptor agonist, used for treatment of chronic liver disease.

HY-B0031S

Quetiapine-d4 fumarate
Quetiapine-d₄ (fumarate) is the deuterium labeled Quetiapine fumarate. Quetiapine fumarate is a 5-HT receptors agonist and a dopamine receptor antagonist. Antidepressant and anxiolytic effects .

HY-100532S

CD437-13C6
CD437- ¹³C₆ is the ¹³C- and deuterium labeled CD437. CD437 is a selective Retinoic Acid Receptor γ (RARγ) agonist.

HY-14546S

Aripiprazole-d8
Aripiprazole-d₈ is the deuterium labeled Aripiprazole, which is a human 5-HT1A receptor partial agonist with a Ki of 4.2 nM.

HY-41700S2

D-Alanine-d1
D-Alanine-d is the deuterium labeled D-Alanine. D-Alanine is a weak GlyR (inhibitory glycine receptor) and PMBA agonist, with an EC₅₀ of 9 mM for GlyR .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks